comparemela.com

Latest Breaking News On - Fusion pharmaceuticals price performance - Page 1 : comparemela.com

Short Interest in Fusion Pharmaceuticals Inc (NASDAQ:FUSN) Declines By 8 3%

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 7,920,000 shares, a drop of 8.3% from the February 29th total of 8,640,000 shares. Based on an average trading volume of 2,210,000 shares, […]

Fusion Pharmaceuticals (NASDAQ:FUSN) Receives Hold Rating from Jonestrading

Jonestrading reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. Several other research firms also recently weighed in on FUSN. Royal Bank of Canada reiterated a sector perform rating and issued a $21.00 target price (up previously from $16.00) […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.